2021 AzPA Convention Banner
Day
Hour
Minute
Second

Check out the Digital Program

June 11-13, 2021

Virtual

The Arizona Pharmacy Association is pleased to present this 2.5 day annual conference that provides continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings. We will be offering a full line up of both live and on-demand CPE sessions.

Can't make it? Don't  worry! All sessions will be recorded so even if you can't dial in live you still will be eligible to receive the same number of CPE's. 

TENTATIVE AGENDA

FRIDAY | JUNE 11th    

5:45PM-7:15PM | OPENING GENERAL SESSION
Cannabis, In the Weeds (Community, Clinical, and the Courtroom)
Mark Boesen, PharmD, JD; Steve Dudley, PharmD, DABAT; Eman Kirolos, PharmD

Pharmacist Learning Objectives:

  • Discuss the changing landscape of cannabis and implications on safety and marketing.
  • Identify relevant clinical evidence and considerations for the use of cannabis in treating chronic conditions.
  • Differentiate the regulatory oversight of cannabis and opioids at the Federal and State level.
  • Discuss the implications of Prop 207 in Arizona.

Technician Objectives:

  • Discuss the changing landscape of cannabis and implications on safety and marketing.
  • Define the applicable cannabis terms.
  • List the approved and unapproved cannabis products.
  • Differentiate the regulatory oversight of cannabis and opioids at the Federal and State level.
  • Discuss the implications of Prop 207 in Arizona.

ACPE UAN: 0100-0000-21-054-L08-P/T
___________________________________________________________________________________________________________________________________________________________________________________________________
7:15PM - 7:30PM | NON-ACCREDITED EDUCATION PROGRAM
Farxiga Update
Gary Telesco, Executive District Sales Manager

Sponsored by AstraZeneca


7:30PM-8:30PM | WELCOME RECEPTION 

Cheer on this years Pharmacy Appreciation Award Winners and participate in a speed networking session to kick off the convention! 

SATURDAY | JUNE 12th    

7:00AM-7:55AM |  EARLY BIRD CE

Fundamentals for Evaluating and Interpreting Real-World Evidence
Barbara Perry, PharmD, MPH; Jon Glover, PharmD

Pharmacist Learning Objectives: (Pharmacist only)

  • Describe the challenges within the United States healthcare landscape.
  • Describe how real-world data (RWD) is used to generate real-world  evidence (RWE).
  • Review guidelines to evaluate RWE studies.
  • Identify how RWE can be used in healthcare decision-making.
  • List the components/framework for RWE.

ACPE UAN 0100-0000-21-010-L04-P


8:00AM-9:30AM | GENERAL SESSION

2021 Pharmacy Law Update
Roger Morris, RPh, JD; Christopher Dang, JD

Pharmacist/Technician Learning Objectives:

  • Describe new legislative updates pertaining to the practice of pharmacy in Arizona.
  • Describe the practical ramifications of proposed state and national legislative initiatives.
  • Recognize emerging patterns that will broadly affect the healthcare profession and
    pharmacy practice.

ACPE UAN 0100-0000-21-030-L03-P/T


9:30AM – 10:00AM | NON-ACCREDITED EDUCATION PROGRAM

Immune Globulin Product Characteristics and Clinical Considerations
Bhavesh Shah, RPh, BCOP

Sponsored by Takeda


10:05AM – 11:05AM |  BREAKOUT SESSIONS

When Lower Isn’t Better: Establishing Glycemic Goals in Older Adults
Taylor Naberhaus, PharmD, BCGP; Nicole Early, PharmD, BCGP, BCPS, FASCP

Pharmacist Learning Objectives: (Pharmacist only)

  • Employ the 2021 American Diabetes Association Standards of Care for Diabetes to identify appropriate glycemic goals for older adults in the ambulatory and long-term care settings.
  • Utilize primary literature to assess risks versus benefits of individual glycemic goals.
  • Given a patient case, implement deprescribing principles to recommend changes to diabetes regimens to simplify diabetes regimens.
  • Discuss appropriate lipid and blood pressure goals in older adults with diabetes as they age.

ACPE UAN 0100-0000-21-031-L01-P

 

Coaching and Development in Pharmacy:  Different Approaches to Influence Behavior and Performance
Jarrod Gonzales, PharmD

Pharmacist/Technician Learning Objectives:

  • Applying the 4 agreements to your leadership style.
  • List the 7 questions to improve the way you lead.
  • Create a comprehensive coaching plan for both an enhancement of skills or correction of actions.
  • List the aspects of a founder’s mentality.
  • List the 4 agreements and explain their importance in leadership.

ACPE UAN 0100-0000-21-032-L04-P/T

 

Biostats 101-A Quick Review for the Board Exams and Improving Patient Care
Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS

Pharmacist Learning Objectives: (Pharmacist only)

  • Identify different types of data (nominal, ordinal, interval/ration) to determine appropriate measure of central tendency, and appropriate test for statistical significance.
  • Define and evaluate odds ratio and risk ratio reported from literature.
  • Interpret statistical significance based on reported odds ratios, risk ratios, or confidence intervals.
  • Define and calculate the absolute risk, relative risk, number needed to treat given data from a study.

ACPE UAN 0100-0000-21-033-L04-P


11:15AM – 12:15PM |  BREAKOUT SESSIONS

Pharmacy Harmony:  3 Keys to Good Hires and Trusting Teams
Juan Kingsbury, BS

Pharmacist/Technician Learning Objectives:

  • Summarize WHY mis-hires happen, where bad attitudes come from and how to avoid both to get back in rhythm.
  • Describe the crucial outcome of a specific pharmacy role.
  • Recognize the varying motivations of pharmacists and pharmacy technicians.
  • Discuss PEER RESPECT and the awareness of individual behavior and how it affects the TEAM.
  • Identify opportunity to improve YOUR pharmacy environment.

ACPE UAN 0100-0000-21-034-L04-P/T

 

Maximizing Your Impact:  Precepting Multiple Learners with a Layered Learning Model
Elizabeth Pogge, PharmD, MPH, BCPS, FASCP, FAzPA; Nicole Early, PharmD, BCGP, BCPS, FASCP; Nana Entsuah, PharmD

Pharmacist Learning Objectives: (Pharmacist only)

  • Identify layered learning as an educational tool for students and residents.
  • Describe benefits and barriers to the layered learning model in pharmacy experiential education.
  • Apply the layered learning model to various practice settings and learners.

ACPE UAN 0100-0000-21-035-L04-P

Biostats 102: Application of Biostats to the Real World
Bernadette Cornelison, PharmD, BS, MS, BCPS; Christopher Edwards, PharmD, BCPS
Pharmacist Learning Objectives: (Pharmacist only)
  • Identify the primary and secondary outcomes in a study.
  • Assess appropriateness of statistical testing used based off of the type of variables being studied.
  • Interpret the results based off the information presented.

ACPE UAN 0100-0000-21-036-L04-P

__________________________________________________________________________

12:15PM - 12:45PM | NON-ACCREDITED EDUCATION PROGRAM

Atypical Hemolytic Uremic Syndrome (aHUS): Understanding the Pathophysiology and Diagnosis of Complement-Mediated Thrombotic Microangiopathy (TMA)
Jake Osmundson PharmD

Sponsored by Alexion Pharmaceuticals, Inc.


1:00PM – 2:30PM | KEYNOTE GENERAL SESSION:

Looking Forward: The Future of Pharmacy
Rebecca Snead, RPh, CAE, FAPhA; RADM Ty Bingham, PharmD; RADM (ret) Pamela Schweitzer, PharmD

Pharmacist/Technician Learning Objectives:

  • Describe the impact of future technology trends on pharmacy practice.
  • Identify ways in which scope of practice advances will change the way pharmacists and technicians practice
  • Discuss the importance of the Pharmacy and Medically Underserved Areas Enhancement Act and what the pharmacy profession can do to help advocate for this change?

ACPE UAN: 0100-0000-21-053-L04-P/T


2:30PM – 3:00PM | NON-ACCREDITED EDUCATION PROGRAM

Overview of Rybelsus and Ozempic
Vicki Walcha, Executive EDCS
Obesity
Courtney L. Walker, PharmD, RPh

Sponsored by Novo Nordisk


3:05PM - 4:05PM |  BREAKOUT SESSIONS

Evidence Based Treatment Overview for “Vaping” Cessation
Jing Li, PharmD, BCPS

Pharmacist Learning Objectives:

  • Describe the nature and impact of the biological, psychological, and socio-cultural factors that influence the use of nicotine products.
  • Identify the aspects of the formulation of ENDS products that influence the health risks and inform rational approaches in the treatment of nicotine use disorders.
  • Demonstrate the rational approaches to reducing nicotine use including prevention strategies, pharmacotherapeutic   regimens, and behavioral interventions.

Technician Learning Objectives:

  • Describe the nature and impact of the biological, psychological, and socio-cultural factors that influence the use of nicotine products.
  • Identify the aspects of products that influence approaches in the treatment of nicotine use disorders.
  • Recognize the rational approaches to reducing nicotine use.

ACPE UAN 0100-0000-21-037-L01-P/T

 

Biosimilars: Knock-Off Biologics or the Answer to High Cost Cancer Treatment?
Alex Wolff, PharmD

Pharmacist Learning Objectives:

  • Discuss recent FDA activity and regulations regarding biologics and biosimilars.
  • Define interchangeability designation.
  • Recognize issues with biosimilar use in electronic prescribing and EMRs.
  • Assess and prepare for potential operational challenges when implementing biosimilars in a health system.

Technician Learning Objectives:

  • Discuss recent FDA activity and regulations regarding biologics and biosimilars.
  • Define interchangeability designation.
  • Recognize issues with biosimilar use in electronic prescribing and EMRs.
  • Recognize potential operational challenges when implementing biosimilars in a health system.

ACPE UAN 0100-0000-21-038-L01-P/T

 

Demystifying Metacognition:  Practical Tools to Improve the Thinking of Yourself and Your Learners
Janet Cooley, PharmD, BCACP; Suzanne Larson, PharmD

Pharmacist Learning Objectives: (Pharmacist only)

  • Describe the relationship between critical thinking and clinical reasoning.
  • Discuss the need to improve thinking amongst pharmacists and pharmacists-in-training.
  • Review the Pharmacists Patient Care Process (PPCP).
  • Describe the Continuing Professional Development (CPD) cycle.

ACPE UAN 0100-9999-21-039-L04-P

SUNDAY | JUNE 13th    

7:00AM-7:55AM |  EARLY BIRD CE
Immunizations: Getting Back to Our "Routine"
Sophia Galloway, PharmD, BCACP; Holly Van Lew, PharmD, BCPS

Pharmacist Learning Objectives:

  • Describe current COVID vaccine recommendations, including proper storage and administration.
  • Assess vaccination status and recommend companion vaccines for patients receiving COVID vaccine.
  • Discuss strategies to increase vaccination rates in your pharmacy or clinic.

Technician Learning Objectives:

  • List the current COVID-19 vaccines that have received an FDA EUA.
  • Describe the differences between doses, storage and handling, and administration of the available COVID-19 vaccines.
  • Discuss strategies to increase vaccination rates in your pharmacy or clinic.

ACPE UAN 0100-0000-21-056-L06-P/T


8:00AM – 9:15AM |  GENERAL SESSION

What We Can Learn by Examining Health Disparities During COVID-19
Cheryl Wisseh, PharmD, MPH; Nancy A. Alvarez, PharmD, BCPS, CPCC, FAPhA; Danielle Gilliam, PharmD, MPH

Pharmacist/Technician Learning Objectives:

  • Describe the connection between health disparities and social determinants of health.
  • Identify the health disparities seen with COVID-19 vaccinations.
  • Explore ways in which pharmacy professionals can apply social determinants of health to clinical practice.

ACPE UAN: 0100-0000-21-055-L04-P/T


9:20AM –10:20AM | BREAKOUT SESSIONS

What’s the Hype about Hypertension?
Kimberly Langley, PharmD, MBA, BCPS; Christopher Tran, PharmD, MBA

Pharmacist Learning Objectives: (Pharmacist only)

  • Review prevalence and management of hypertension in the general population.
  • Discuss the challenges of treating hypertension in the inpatient setting.
  • Summarize available clinical evidence for the inpatient treatment of hypertension.
  • Identify appropriate treatment of hypertensive emergency in the inpatient setting.

ACPE UAN 0100-0000-21-040-L01-P

 

Back to Basics and the Future:  A Primer in Pediatric Patients
Titilola Afolabi, PharmD, BCPPS

Pharmacist Learning Objectives: (Pharmacist only)

  • Describe age-related physiologic changes as a patient progresses through infancy and childhood.
  • Predict how physiological differences affect PK parameters.
  • Identify how pharmacodynamics and pharmacogenomics impact drug selection or dosing to maximize efficacy and
    minimize adverse effects.
  • Given a patient case, formulate a treatment regimen incorporating principles of developmental pharmacology.

ACPE UAN 0100-0000-21-042-L01-P

 

Ready, Aim, Fire:  Off-Target Toxicity in Cancer Treatment
Meredith Higley, PharmD, BCOP

Pharmacist Learning Objectives: (Pharmacist only)

  • Define off-target toxicity and differentiate it from other types of drug toxicity.
  • List 3 examples of off-target toxicity in cancer treatment.
  • Identify drug development techniques to mitigate off-target toxicity.
  • Recommend strategies for management of off-target toxicity.

ACPE UAN 0100-0000-21-043-L01-P


10:20AM - 10:50AM | NON-ACCREDITED EDUCATION PROGRAM
VASCEPA® (icosapent ethyl): Elevating the Standard of Care (The Role of the Pharmacist)
Jennifer Goldman, PharmD, CDES, BC-ADM, FCCP

Sponsored by Amarin Pharma Inc. 


11:00AM – 12:30PM |  BREAKOUT SESSIONS

From A-Z: Clinical Pearls for Pharmacy Professionals
Jacob Schwarz, PharmD, MBA, BCIDP, BCCP, BCPS; Nicole Scovis, PharmD, BCPS, BCACP, CMWA; Nana Entsuah, PharmD 

Pharmacist Learning Objectives:

  • Evaluate clinical scenarios or “clinical pearls” that might not be widely known or published.
  • Apply novel clinical practice options for patient care in various health settings.
  • Describe medication management strategies in difficult or controversial patient care situations.
  • Assemble clinical information that can be applied to applicable work settings.

Technician Learning Objectives:

  • Describe clinical scenarios or “clinical pearls” that might not be widely known or published.
  • Recognize novel practice options and medication management strategies for patient care.

ACPE UAN 0100-0000-21-044-L01-P/T

 

What’s Currently Smoking?  Evidence-based Treatment Options in Tobacco Cessation Interventions
Jing Li, PharmD, BCPS

Pharmacist Learning Objectives:

  • Define the chronic condition of commercial tobacco use.
  • Identify the 3 link-chain of addiction.
  • Review of current guideline on the treatment of tobacco cessation intervention, addressing the pharmacotherapy and behavior health.

Technician Learning Objectives:

  • Define the chronic condition of commercial tobacco use.
  • Identify the 3 link-chain of addiction.
  • Identify current treatment options for tobacco cessation intervention.

ACPE UAN 0100-0000-21-045-L01-P/T

 

Advances in Pharmacotherapy
Robert J. Lipsy, PharmD, BCACP, FASHP, FAzPA

Pharmacist Learning Objectives:

  • Compare and contrast newly approved medications to current ones used to treat the same condition.
  • Identify the most appropriate medication to treat a condition based on population and individual patient information.
  • Describe the risks and benefits of new medications to other healthcare providers.

Technician Learning Objectives:

  • Aid the pharmacist in choosing the most appropriate drug therapy by providing medication information.
  • Recognize what laboratory tests are usually association with a specific condition.
  • List the appropriate way(s) to store medications following dispensing.

ACPE UAN 0100-0000-21-046-L01-P/T


12:45PM – 1:15PM | NON-ACCREDITED EDUCATION PROGRAM

MedWise® – A Cutting Edge, Advanced Clinical Decision Support Tool
Nicole Scovis, PharmD, BCPS, BCACP, CMWA

Sponsored by Tabula Rasa Healthcare

1:20PM – 2:20PM |  BREAKOUT SESSIONS

Diabetes Management in Patients with Chronic Kidney Disease
Maura Jones, PharmD, BCPS; Rim Hadgu, PharmD, BCPS

Pharmacist Learning Objectives: (pharmacist only)

  • Describe the effect of diabetes on renal dysfunction.
  • Analyze literature on the use of antidiabetic agents to reduce cardiovascular disease and progression of CKD to ESRD.
  • Evaluate safety and efficacy of oral and injectable antidiabetic agents in patients undergoing hemodialysis.

ACPE UAN 0100-0000-21-047-L01-P

 

HIV Update 2021
Lauren Lawler, PharmD, AAHIVP

Pharmacist Learning Objectives:

  • Describe HIV epidemiology, diagnostic criteria, and clinical presentation.
  • Review HIV treatment guidelines.
  • Recognize medications used in the treatment of HIV.

Technician Learning Objectives:

  • Describe HIV epidemiology and clinical presentation.
  • Recognize medications used in the treatment of HIV.

ACPE UAN 0100-0000-21-048-L01-P/T

 

Deprescribing: First, Do No Harm
William N. Jones, MS, RPh
Pharmacist/Technician Learning Objectives:
  • Define deprescribing.
  • List 2 benefits of deprescribing.
  • List 2 barriers to deprescribing.
  • Recognize the importance of patient safety first when deprescribing.

ACPE UAN 0100-0000-21-049-L05-P/T


2:30PM – 3:30PM | 2021 AWARDS PROGRAM & BOARD OF DIRECTORS INSTALLMENT

 

 

 

 

 

 

acpe logo

Accreditation Information 

The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE).

To obtain CPE credit for any of the LIVE sessions, learners must attend the session live, enter the session code, and complete the assessment quiz and evaluation for each session attended. The session code and further instructions will be provided at the end of each LIVE session. The deadline to claim credit for attending the live sessions is August 11, 2021.

  • Learning Level: Varies
  • Activity Type: Knowledge and Application-based
  • Target Audience: Pharmacists and Technicians

 

Disclosures

Disclosures will be announced at the beginning of each session and can be found in the Event Program under each speaker(s) biography. AzPA CE staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity.

Conflicts of interest have been resolved through content review by the AzPA CE Committee Department and Committee.

 

Thank You to Our Generous Sponsors